These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25669601)

  • 1. The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases.
    Son M; Wypasek E; Celinska-Lowenhoff M; Undas A
    Thromb Res; 2015 May; 135(5):1035-6. PubMed ID: 25669601
    [No Abstract]   [Full Text] [Related]  

  • 2. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
    Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
    Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
    Cohen H; Hunt BJ; Efthymiou M; Arachchillage DR; Mackie IJ; Clawson S; Sylvestre Y; Machin SJ; Bertolaccini ML; Ruiz-Castellano M; Muirhead N; Doré CJ; Khamashta M; Isenberg DA;
    Lancet Haematol; 2016 Sep; 3(9):e426-36. PubMed ID: 27570089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism.
    Sciascia S; Breen K; Hunt BJ
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):476-7. PubMed ID: 25923780
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: Rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.
    Pengo V; Banzato A; Bison E; Zoppellaro G; Padayattil Jose S; Denas G
    Lupus; 2016 Mar; 25(3):301-6. PubMed ID: 26466613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism.
    Arachchillage DR; Mackie IJ; Efthymiou M; Chitolie A; Hunt BJ; Isenberg DA; Khamashta M; Machin SJ; Cohen H
    J Thromb Haemost; 2016 Nov; 14(11):2177-2186. PubMed ID: 27541499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral Venous Thromboembolism in Antiphospholipid Syndrome Successfully Treated with the Combined Use of an Anti-Xa Inhibitor and Corticosteroid.
    Sugie M; Iizuka N; Shimizu Y; Ichikawa H
    Intern Med; 2015; 54(23):3051-6. PubMed ID: 26631891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catastrophic antiphospholipid antibody syndrome in pediatric systemic lupus erythematosus.
    Falcini F; Taccetti G; Ermini M; Trapani S; Matucci Cerinic M
    J Rheumatol; 1997 Feb; 24(2):389-92. PubMed ID: 9035002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of dabigatran and rivaroxaban to prevent thromboembolism in antiphospholipid syndrome: a case series of three patients.
    Schaefer JK; McBane RD; Black DF; Williams LN; Moder KG; Wysokinski WE
    Thromb Haemost; 2014 Nov; 112(5):947-50. PubMed ID: 25118790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A young woman with systemic lupus erythematosus and extensive mesenteric vasculitis involving small and medium vessels.
    Ashouri JF; Davis JL; Farkas A; Durack JC; Ramachandran R; Dall'Era M
    Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1928-33. PubMed ID: 22933330
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparing APLS and oranges: caution with the use of direct-acting oral anticoagulants (DOACs) instead of warfarin in the treatment of antiphospholipid syndrome (APLS).
    Benger M; Vink J; Snell LB; Breen K
    BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30940667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic principles in systemic lupus erythematosis with phospholipid syndrome].
    Reshetniak TM; Alekberova ZS; Nasonov EL; Nasonova VA
    Ter Arkh; 1998; 70(5):83-7. PubMed ID: 9644754
    [No Abstract]   [Full Text] [Related]  

  • 13. A new dawn of anticoagulation for patients with antiphospholipid syndrome?
    Giles I; Khamashta M; D'Cruz D; Cohen H
    Lupus; 2012 Oct; 21(12):1263-5. PubMed ID: 23015650
    [No Abstract]   [Full Text] [Related]  

  • 14. Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome.
    Ann Intern Med; 2019 Nov; 171(10):. PubMed ID: 31610579
    [No Abstract]   [Full Text] [Related]  

  • 15. [Not Available].
    Bauersachs R; Schellong S; Stücker M; Oldenburg J; Kalka C; Scholz U; Lindhoff-Last E
    Hamostaseologie; 2019 Aug; 39(3):298-300. PubMed ID: 31404932
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of antiphospholipid antibody positivity and elective orthopedic procedures.
    Schnitz WM; Lister KA; McCarty GA
    Lupus; 1992 May; 1(3):187-9. PubMed ID: 1301980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation in the antiphospholipid syndrome.
    Casais P; Alberto MF; Gennari LC; Grosso SH; Meschengieser SS; Lazzari MA
    Haematologica; 2004 Apr; 89(4):503-4. PubMed ID: 15075090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to manage patients with systemic lupus erythematosus who are also antiphospholipid antibody positive.
    Giles I; Rahman A
    Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):525-37. PubMed ID: 19591782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of Libman-Sacks Endocarditis With Combined Hydroxychloroquine-Vitamin K Antagonist Therapy in a Primary Antiphospholipid Syndrome Patient.
    Omarjee L; Jaquinandi V; Camarzana A; Rouleau F; Mezdad TH; Le Tourneau T; Mahe G; Belizna C
    Circ J; 2018 Aug; 82(9):2380-2382. PubMed ID: 29467357
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature.
    Dufrost V; Risse J; Zuily S; Wahl D
    Curr Rheumatol Rep; 2016 Dec; 18(12):74. PubMed ID: 27812956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.